Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.

about

Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.

Item

http://www.wikidata.org/entity/Q44348609

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@en

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@nl

type

Item

label

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@en

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@nl

prefLabel

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@en

Medication-Assisted Treatment ...... ates: Critique and Commentary.

@nl

P1476

Medication-Assisted Treatment ...... tates: Critique and Commentary

@en

P2093

Karen McElrath

http://www.w3.org/2001/XMLSchema#string

P2860

Substitution treatment of injecting opioid users for prevention of HIV infection

Factors affecting willingness to provide buprenorphine treatment.

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience

Correlates of methadone client retention: a prospective cohort study in Guizhou province, China

Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels

A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users

Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context.

Supply of buprenorphine waivered physicians: the influence of state policies.

P304

334-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10826084.2017.1342662

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karen McElrath

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28862903

http://www.w3.org/2001/XMLSchema#string